Steven W Lefkowitz
CIK 1313149 · Interim Chief Financial Ofcr · last filed 2026-01-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$940.4K
Companies
3
Total Filings
54
Lifetime Open-Market Net
-$798.8K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CRMD | Director | 127,951 | $7.35 | $940.4K | -$817.4K | 27 | 2026-01-27 |
| CorMedix Inc. (CRMD.WS) Delisted | Interim Chief Financial Ofcr | 166,471 | — | — | $18.6K | 20 | 2015-04-27 |
| FRANKLIN CREDIT HOLDING CORP/DE/ (FCMC) Delisted | Director | — | — | — | $0 | 2 | 2008-07-17 |
Recent Filings · Page 3 of 6
54 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-12-14 | CRMD | Buy (P) | +135,416 | $65.0K | EDGAR |
| 2017-06-28 | CRMD | Grant (A) | — | $0 | EDGAR |
| 2016-06-03 | CRMD | Exer (M) | +100,000 | $68.0K | EDGAR |
| 2016-06-01 | CRMD | Sell (S) | −50,000 | -$144.2K | EDGAR |
| 2016-05-23 | CRMD | Mixed | +20,000 | -$54.0K | EDGAR |
| 2016-02-24 | CRMD | Grant (A) | — | $0 | EDGAR |
| 2016-02-04 | CRMD | Exer (M) | +30,000 | $8.7K | EDGAR |
| 2015-06-01 | CRMD | Sell (S) | −39,072 | -$255.1K | EDGAR |
| 2015-04-27 | CorMedix Inc. (CRMD.WS) Delisted | Exer (X) | +32,436 | $111.5K | EDGAR |
| 2015-03-03 | CorMedix Inc. (CRMD.WS) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.